Seamark Bio-Organic Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 12-12-2024
- Paid Up Capital ₹ 0.40 M
as on 12-12-2024
- Company Age 21 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.20 M
as on 12-12-2024
- Satisfied Charges ₹ 5.00 M
as on 12-12-2024
About Seamark Bio-Organic
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 0.40 M.
The company currently has active open charges totaling ₹9.20 M. The company has closed loans amounting to ₹5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Sasmita Behera and Arbin Kumar serve as directors at the Company.
- CIN/LLPIN
U24232OR2002PTC007012
- Company No.
007012
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Dec 2002
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Khorda, Odisha, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Seamark Bio-Organic?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sasmita Behera  | Managing Director | 30-Dec-2002 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Arbin Kumar | Director | 01-Jul-2019 | Current |
Financial Performance of Seamark Bio-Organic.
Seamark Bio-Organic Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Seamark Bio-Organic?
In 2017, Seamark Bio-Organic had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Incroyable Agricole Private LimitedActive 4 years 6 daysSasmita Behera and Arbin Kumar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 Mar 2023 | ₹2.20 M | Open |
Others Creation Date: 22 Aug 2019 | ₹4.80 M | Open |
United Bank Of India Creation Date: 13 Sep 2018 | ₹2.20 M | Open |
How Many Employees Work at Seamark Bio-Organic?
Seamark Bio-Organic has a workforce of 59 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Seamark Bio-Organic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Seamark Bio-Organic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
